Molecular mechanisms oftreg-mediatedt cell suppression

Frontiers in Immunology

Volumn 3, Issue MAR, 2012, Pages

  Schmidt, Angelika ^a   Oberle, Nina ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Suppression mechanisms; Treg,TCR signaling

Indexed keywords

EID: 84866467129     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00051     Document Type: Review

References (245)

1. Abbracchio, M. P., Burnstock, G., Boey-naems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fuma-galli, M., Gachet, C., Jacobson, K. A., and Weisman, G. A. (2006). Inter-national Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and patho-physiology to therapy. Pharmacol. Rev. 58, 281-341.
2. Acuto, O., and Michel, F. (2003). CD28-mediated co-stimulation: a quanti-tative support for TCR signalling. Nat. Rev. Immunol. 3, 939-951.
3. Ahern,P. P.,Schiering,C.,Buonocore,S., McGeachy,M. J.,Cua,D. J.,Maloy,K. J.,and Powrie,F. (2010). Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279-288.
4. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bac-chetta, R., Roncarolo, M. G., and Levings, M. K. (2007). Activation-induced FOXP3 in human T effec-tor cells does not suppress prolif-eration or cytokine production. Int. Immunol. 19, 345-354.
5. Allan, S. E., Song-Zhao, G. X.,Abraham, T.,McMurchy,A. N.,and Levings,M. K. (2008). Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol. 38, 3282-3289.
6. Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., 'Shea, J. J., and Shevach, E. M. (2008). CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205, 1975-1981.
7. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999). An essential role for inter-leukin 10 in the function of reg-ulatory T cells that inhibit intesti-nal inflammation. J. Exp. Med. 190, 995-1004.
8. Asseman, C., Read, S., and Powrie, F. (2003). Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171, 971-978.
9. Baatar, D., Olkhanud, P. B., Wells, V., Indig,F. E.,Mallucci,L.,and Biragyn, A. (2009). Tregs utilize beta-galactoside-binding protein to tran-siently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation. Brain Behav. Immun. 23, 1028-1037.
10. Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W., and Kopf, M. (1999). Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131.
11. Baecher-Allan, C., Brown, J. A., Free-man, G. J., and Hafler, D. A. (2001). CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253.
12. Baecher-Allan, C., Viglietta, V., and Hafler, D. A. (2002). Inhibition of human CD4(+)CD25(+high) regu-latory T cell function. J. Immunol. 169, 6210-6217.
13. Baecher-Allan, C., Wolf, E., and Hafler, D. A. (2006). MHC class II expres-sion identifies functionally dis-tinct human regulatory T cells. J. Immunol. 176, 4622-4631.
14. Bandyopadhyay,S.,Soto-Nieves,N.,and Macian, F. (2007). Transcriptional regulation of T cell tolerance. Semin. Immunol. 19, 180-187.
15. Bardel, E., Larousserie, F., Charlot-Rabiega, P., Coulomb-L'Hermine, A., and Devergne, O. (2008). Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol. 181, 6898-6905.
16. Barthlott, T., Moncrieffe, H., Veld-hoen, M., Atkins, C. J., Christensen, J., 'Garra, A., and Stockinger, B. (2005). CD25+ CD4+ T cells com-pete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int. Immunol. 17, 279-288.
17. Bazhin, A. V., Kahnert, S., Kimpfler, S., Schadendorf, D., and Umansky, V. (2010). Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells. Mol. Immunol. 47, 678-684.
18. Belkaid, Y. (2007). Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7, 875-888.
19. Ben Ahmed, M., Belhadj, H. N., Moes, N., Buyse, S., Abdeladhim, M., Louzir, H., and Cerf-Bensussan, N. (2009). IL-15 renders conventional lymphocytes resistant to suppres-sive functions of regulatory T cells through activation of the phos-phatidylinositol 3-kinase pathway. J. Immunol. 182, 6763-6770.
20. Beriou, G., Costantino, C. M., Ash-ley, C. W., Yang, L., Kuchroo, V. K., Baecher-Allan, C., and Hafler, D. A. (2009). IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113, 4240-4249.
21. Beyer, M., and Schultze, J. L. (2007). CD4+CD25highFOXP3+ regu-latory T cells in peripheral blood are primarily of effector memory phenotype. J. Clin. Oncol. 25, 2628-2630.
22. Birebent, B., Lorho, R., Lechartier, H., de Guibert, S., Alizadeh, M., Vu, N., Beauplet,A., Robillard, N., and Sem-ana, G. (2004). Suppressive proper-ties of human CD4+CD25+ regula-tory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34, 3485-3496.
23. Bodor, J., Bodorova, J., and Gress, R. E. (2000). Suppression of T cell func-tion: a potential role for transcrip-tional repressor ICER. J. Leukoc. Biol. 67, 774-779.
24. Bodor, J., Fehervari, Z., Diamond, B., and Sakaguchi, S. (2007a). ICER/CREM-mediated transcrip-tional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur. J. Immunol. 37, 884-895.
25. Bodor, J., Fehervari, Z., Diamond, B., and Sakaguchi, S. (2007b). Regu-latory T cell-mediated suppression: potential role of ICER. J. Leukoc. Biol. 81, 161-167.
26. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Ser-fling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., Stoll, S., Schild, H., Staege, M. S., Stassen, M., Jonuleit, H., and Schmitt, E. (2007). Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310.
27. Bopp, T., Palmetshofer, A., Serfling, E., Heib, V., Schmitt, S., Richter, C., Klein, M., Schild, H., Schmitt, E., and Stassen, M. (2005). NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J. Exp. Med. 201, 181-187.
28. Borsellino, G., Kleinewietfeld, M., Di, M. D., Sternjak, A., Diamantini, A., Giometto, R., Hopner, S., Cen-tonze, D., Bernardi, G., Dell'Acqua, M. L., Rossini, P. M., Battistini, L., Rotzschke, O., and Falk, K. (2007). Expression of ectonucleoti-dase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232.
29. Buckner, J. H. (2010). Mecha-nisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoim-mune diseases. Nat. Rev. Immunol. 10, 849-859.
30. Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., and Ley, T. J. (2007). Granzyme B and perforin are important for reg-ulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646.
31. Cederbom, L., Hall, H., and Ivars, F. (2000). CD4+CD25+ regula-tory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543.
32. Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J., and Vignali, D. A. (2011). Cutting edge: human reg-ulatory T cells require IL-35 to medi-ate suppression and infectious toler-ance. J. Immunol. 186, 6661-6666.
33. Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., and Rudensky, A. Y. (2009). CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991.
34. Chaudhry, A., Samstein, R. M., Treut-ing, P., Liang, Y., Pils, M. C., Hein-rich, J. M., Jack, R. S., Wunderlich, F. T., Bruning, J. C., Muller, W., and Rudensky, A. Y. (2011). Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immu-nity 34, 566-578.
35. Chauhan, S. K., El Annan, J., Ecoiffier, T., Goyal, S., Zhang, Q., Saban, D. R., and Dana, R. (2009). Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J. Immunol. 182, 1247-1252.
36. Chinenov, Y., and Kerppola, T. K. (2001). Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438-2452
37. Chuang, H. C., Lan, J. L., Chen, D. Y., Yang, C. Y., Chen, Y. M., Li, J. P., Huang, C. Y., Liu, P. E., Wang, X., and Tan, T. H. (2011). The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells. Nat. Immunol. 12, 1113-1118.
38. Collison, L. W., Chaturvedi, V., Hender-son, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., Rehg, J. E., Jones, M. L., Ni, H. T., Artis, D., Turk, M. J., and Vig-nali, D. A. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101.
39. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blum-Berg, R. S., and Vignali, D. A. (2007). The inhibitory cytokine IL-35 con-tributes to regulatory T-cell func-tion. Nature 450, 566-569.
40. Curiel, T. J. (2008). Regulatory T cells and treatment of cancer. Curr. Opin. Immunol. 20, 241-246.
41. Curotto de Lafaille, M. A., and Lafaille, J. J. (2009). Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30, 626-635.
42. Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S.,Durelli,I.,Horenstein,A. L.,Fiore, F., Massaia, M., Colombo, M. P., Baccarani, M., and Lemoli, R. M. (2007). Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25-into CD25+ T regulatory cells. Blood 109, 2871-2877.
43. de la Rosa, M., Rutz, S., Dorninger, H., and Scheffold, A. (2004). Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480-2488.
44. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo,V. K., Strom, T. B., and Robson, S. C. (2007). Adeno-sine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265.
45. Dieckmann, D., Plottner, H., Berch-told, S., Berger, T., and Schuler, G. (2001). Ex vivo isolation and char-acterization of CD4(+)CD25(+)T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303-1310.
46. Dong, C., Davis, R. J., and Flavell, R. A. (2002). MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
47. Durant, L., Watford, W. T., Ramos, H. L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H. W., Kanno,Y., Powrie, F., and 'Shea, J. J. (2010). Diverse targets of the transcrip-tion factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605-615.
48. Edin, S., Oruganti, S. R., Grundstrom, C., and Grundstrom, T. (2010). Interaction of calmodulin with Bcl10 modulates NF-kappaB activa-tion. Mol. Immunol. 47, 2057-2064.
49. Ermann, J., Szanya, V., Ford, G. S., Para-gas, V., Fathman, C. G., and Lejon, K. (2001). CD4(+)CD25(+)Tcells facilitate the induction of T cell anergy. J. Immunol. 167, 4271-4275.
50. Ernst, P. B., Garrison, J. C., and Thomp-son, L. F. (2010). Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol. 185, 1993-1998.
51. Esquerre, M., Tauzin, B., Guiraud, M., Muller, S., Saoudi, A., and Valitutti, S. (2008). Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 105, 2550-2555.
52. Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., and Powrie, F. (2005). T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201, 737-746.
53. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., and Puccetti, P. (2003). Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212.
54. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., San-tamaria, P., Fioretti, M. C., and Puccetti, P. (2006). The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752-6761.
55. Fassbender, M., Gerlitzki, B., Ullrich, N., Lupp, C., Klein, M., Radsak, M. P., Schmitt, E., Bopp, T., and Schild, H. (2010). Cyclic adenosine monophosphate and IL-10 coor-dinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell. Immunol. 265, 91-96.
56. Feske, S. (2007). Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7, 690-702.
57. Feske, S., Prakriya, M., Rao, A., and Lewis, R. S. (2005). A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients. J. Exp. Med. 202, 651-662.
58. Feuerer, M., Hill, J. A., Kretschmer, K., von Boehmer, H., Mathis, D., and Benoist, C. (2010). Genomic defini-tion of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. U.S.A. 107, 5919-5924.
59. Feuerer, M., Hill, J. A., Mathis, D., and Benoist, C. (2009). Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10, 689-695.
60. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
61. Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S.,Albrecht, M., Nothnagel, M., Ellinghaus, D., Sina, C., Onnie, C. M., Weersma, R. K., Stokkers, P. C., Wijmenga, C., Gazouli, M., Strachan, D., McAr-dle, W. L., Vermeire, S., Rutgeerts, P., Rosenstiel, P., Krawczak, M.,Vatn, M. H., Mathew, C. G., and Schreiber, S. (2008). Sequence variants in IL10, ARPC2 and multiple other loci con-tribute to ulcerative colitis suscepti-bility. Nat. Genet. 40, 1319-1323.
62. Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Kincaid, R. L., Tocci, M. J., 'Keefe, S. J., and 'Neill, E. A. (1994). Cal-cineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J. 13, 861-870.
63. Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M., Der, S. D., Kang, J., and Chambers, C. A. (2009). CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 206, 421-434.
64. Frischbutter, S., Gabriel, C., Bendfeldt, H., Radbruch, A., and Baumgrass, R. (2011). Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-kappaB activation in Th cells. Eur. J. Immunol. 41, 2349-2357.
65. Gasser, A., Bruhn, S., and Guse, A. H. (2006). Second messenger func-tion of nicotinic acid adenine din-ucleotide phosphate revealed by an improved enzymatic cycling assay. J. Biol. Chem. 281, 16906-16913.
66. Gavin, M. A., Torgerson, T. R., Hous-ton, E., DeRoos, P., Ho, W. Y., Stray-Pedersen,A., Ocheltree, E. L., Green-Berg, P. D., Ochs, H. D., and Ruden-Sky, A. Y. (2006). Single-cell analy-sis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell develop-ment. Proc. Natl. Acad. Sci. U.S.A. 103, 6659-6664.
67. Gershon, R. K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: the role of thymic lym-phocytes. Immunology 18, 723-737.
68. Glocker, E. O., Kotlarz, D., Boztug, K., Gertz, E. M., Schaffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., All-Roth, A., Murugan, D., Hatscher, N., Pfeifer, D., Sykora, K. W., Sauer, M., Kreipe, H., Lacher, M., Nustede, R., Woellner, C., Baumann, U., Salzer, U., Koletzko, S., Shah, N., Segal, A. W., Sauerbrey, A., Buderus, S., Snap-per, S. B., Grimbacher, B., and Klein, C. (2009). Inflammatory bowel dis-ease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045.
69. Godfrey, W. R., Spoden, D. J., Ge, Y. G., Baker, S. R., Liu, B., Levine, B. L., June, C. H., Blazar, B. R., and Porter, S. B. (2005). Cord blood CD4(+)CD25(+)-derived T regula-tory cell lines express FoxP3 pro-tein and manifest potent suppressor function. Blood 105, 750-758.
70. Gondek, D. C., Devries, V., Nowak, E. C., Lu, L. F., Bennett, K. A., Scott, Z. A., and Noelle, R. J. (2008). Trans-plantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells. J. Immunol. 181, 4752-4760.
71. Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S., and Noelle, R. J. (2005). Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786.
72. Gounaris, E., Blatner, N. R., Dennis, K., Magnusson, F., Gurish, M. F., Strom, T. B., Beckhove, P., Gounari, F., and Khazaie, K. (2009). T-regulatory cells shift from a protec-tive anti-inflammatory to a cancer-promoting proinflammatory phe-notype in polyposis. Cancer Res. 69, 5490-5497.
73. Grafton, G., and Thwaite, L. (2001). Calcium channels in lymphocytes. Immunology 104, 119-126.
74. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., and Pucillo, C. E. (2008). CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29, 771-781.
75. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., and Ley,T. J. (2004). Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601.
76. Guse, A. H., da Silva, C. P., Berg, I., Skapenko, A. L., Weber, K., Heyer, P., Hohenegger, M., Ashamu, G. A., Schulze-Koops, H., Potter, B. V., and Mayr, G. W. (1999). Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 398, 70-73.
77. Hanig, J., and Lutz, M. B. (2008). Sup-pression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J. Immunol. 180, 1405-1413.
78. Hermann-Kleiter, N., and Baier, G. (2010). NFAT pulls the strings dur-ing CD4+ T helper cell effector functions. Blood 115, 2989-2997.
79. Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R., and Edinger, M. (2006). Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108, 4260-4267.
80. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the tran-scription factor Foxp3. Science 299, 1057-1061.
81. Huang, C. T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowal-Ski, J., Levitsky, H. I., Powell, J. D., Pardoll, D. M., Drake, C. G., andVig-nali, D. A. (2004). Role of LAG-3 in regulatory T cells. Immunity 21, 503-513.
82. Huber, M., Steinwald, V., Guralnik, A., Brustle, A., Kleemann, P., Rosen-planter, C., Decker, T., and Lohoff, M. (2008). IL-27 inhibits the devel-opment of regulatory T cells via STAT3. Int. Immunol. 20, 223-234.
83. Huber, S., Gagliani, N., Esplugues, E., 'Connor, W. Jr., Huber, F. J., Chaudhry, A., Kamanaka, M., Kobayashi, Y., Booth, C. J., Ruden-sky,A.Y.,Roncarolo,M. G.,Battaglia, M., and Flavell, R. A. (2011). Th17 cells express interleukin-10 recep-tor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent man-ner. Immunity 34, 554-565.
84. Isakov, N., and Altman, A. (2002). Pro-tein kinase C(theta) in T cell acti-vation. Annu. Rev. Immunol. 20, 761-794.
85. Ishiguro, K., Green, T., Rapley, J., Wach-tel, H., Giallourakis, C., Landry, A., Cao, Z., Lu, N., Takafumi, A., Goto, H., Daly, M. J., and Xavier, R. J. (2006). Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation. Mol. Cell. Biol. 26, 5497-5508.
86. Izcue, A., Coombes, J. L., and Powrie, F. (2009). Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313-338.
87. Jain, J., Loh, C., and Rao, A. (1995). Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7, 333-342.
88. Jain, J., McCaffrey, P. G., Miner, Z., Kerppola, T. K., Lambert, J. N., Ver-dine, G. L., Curran, T., and Rao, A. (1993). The T-cell transcription factor NFATp is a substrate for cal-cineurin and interacts with Fos and Jun. Nature 365, 352-355.
89. Johnson, G. L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
90. Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J., and Enk, A. H. (2002). Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196, 255-260.
91. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg,A.,Knop,J.,and Enk,A. H. (2001). Identification and func-tional characterization of human CD4(+)CD25(+) T cells with reg-ulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294.
92. Kamanaka, M., Huber, S., Zenewicz, L. A., Gagliani, N., Rathinam, C., 'Connor, W. Jr., Wan, Y. Y., Nakae, S., Iwakura, Y., Hao, L., and Flavell, R. A. (2011). Mem-ory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intesti-nal pathology. J. Exp. Med. 208, 1027-1040.
93. Karim, M., Feng, G., Wood, K. J., and Bushell, A. R. (2005). CD25+CD4+ regulatory T cells generated by expo-sure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 105, 4871-4877.
94. Khattri, R., Cox, T., Yasayko, S. A., and Ramsdell, F. (2003). An essen-tial role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337-342.
95. King, C. G., Kobayashi, T., Cejas, P. J., Kim, T., Yoon, K., Kim, G. K., Chif-foleau, E., Hickman, S. P., Walsh, P. T., Turka, L. A., and Choi, Y. (2006). TRAF6 is a T cell-intrinsic negative regulator required for the mainte-nance of immune homeostasis. Nat. Med. 12, 1088-1092.
96. Klein, L., Khazaie, K., and von Boehmer, H. (2003). In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. U.S.A. 100, 8886-8891.
97. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., and Mosmann, T. R. (2006). T reg-ulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophos-phate to adenosine. J. Immunol. 177, 6780-6786.
98. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., and Campbell, D. J. (2009). The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflamma-tion. Nat. Immunol. 10, 595-602.
99. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M., and Joosten, I. (2008). Human CD25highFoxp3pos regu-latory T cells differentiate into IL-17-producing cells. Blood 112, 2340-2352.
100. Kojima, H., Kanno, Y., Hase, H., and Kobata, T. (2005). CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed imma-ture CD8+ CTLs during functional maturation. J. Immunol. 174, 5959-5967.
101. Krummel,M. F.,andAllison,J. P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progres-sion upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
102. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
103. Lee, K. Y., D'Acquisto, F., Hayden, M. S., Shim, J. H., and Ghosh, S. (2005). PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 308, 114-118.
104. Lee, Y. K., Mukasa, R., Hatton, R. D., and Weaver, C. T. (2009). Devel-opmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 21, 274-280.
105. Levings, M. K., Sangregorio, R., and Roncarolo, M. G. (2001). Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295-1302.
106. Levings, M. K., Sangregorio, R., Sarti-rana, C., Moschin, A. L., Battaglia, M., Orban, P. C., and Roncarolo, M. G. (2002). Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta,but not interleukin 10, and are distinct fromtype1Tregulatory cells. J. Exp. Med. 196, 1335-1346.
107. Li, M., Lin, J., Wang, Z., He, S., Ma, X., and Li, D. (2010). Oxidized low-density lipoprotein-induced proin-flammatory cytokine response in macrophages are suppressed by CD4CD25(+)Foxp3(+) regulatory T cells through downregulating toll like receptor 2-mediated activa-tion of NF-kappaB. Cell. Physiol. Biochem. 25, 649-656.
108. Li, M. O., Sanjabi, S., and Flavell, R. A. (2006a). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immu-nity 25, 455-471.
109. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K., and Flavell, R. A. (2006b). Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99-146.
110. Li, M. O., Wan, Y. Y., and Flavell, R. A. (2007). T cell-produced transform-ing growth factor-beta1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26, 579-591.
111. Li, Q., and Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
112. Liang,B.,Workman,C.,Lee,J.,Chew,C., Dale, B. M., Colonna, L., Flores, M., Li, N., Schweighoffer, E., Greenberg, S., Tybulewicz, V., Vignali, D., and Clynes, R. (2008). Regulatory T cells inhibit dendritic cells by lympho-cyte activation gene-3 engagement of MHC class II. J. Immunol. 180, 5916-5926.
113. Lin, J., and Weiss, A. (2001). T cell receptor signalling. J. Cell. Sci. 114, 243-244.
114. Liu, Y., Graham, C., Li, A., Fisher, R. J., and Shaw, S. (2002). Phospho-rylation of the protein kinase C-theta activation loop and hydropho-bic motif regulates its kinase activity, but only activation loop phosphory-lation is critical to in vivo nuclear-factor-kappaB induction. Biochem. J. 361, 255-265.
115. Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F.,Varona, R., Rieth-macher, D., Si-Tahar, M., Di Santo, J. P., and Eberl, G. (2008). In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381-1393.
116. Macian, F. (2005). NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472-484.
117. Macian, F., Garcia-Cozar, F., Im, S. H., Horton, H. F., Byrne, M. C., and Rao, A. (2002). Transcriptional mecha-nisms underlying lymphocyte toler-ance. Cell 109, 719-731.
118. Macian, F., Lopez-Rodriguez, C., and Rao,A. (2001). Partners in transcrip-tion: NFAT and AP-1. Oncogene 20, 2476-2489.
119. Mamura, M., Lee, W., Sullivan, T. J., Felici, A., Sowers, A. L., Allison, J. P., and Letterio, J. J. (2004). CD28 dis-ruption exacerbates inflammation in Tgf-beta1-/-mice: in vivo suppres-sion by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood 103, 4594-4601.
120. Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., and Whiteside, T. L. (2010). Generation and accumulation of immuno-suppressive adenosine by human CD4+CD25highFOXP3+ regu-latory T cells. J. Biol. Chem. 285, 7176-7186.
121. Mandapathil, M., Lang, S., Gorelik, E., and Whiteside, T. L. (2009). Isola-tion of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expres-sion. J. Immunol. Methods 346, 55-63.
122. Manicassamy, S., Gupta, S., and Sun, Z. (2006a). Selective function of PKC-theta in T cells. Cell. Mol. Immunol. 3, 263-270.
123. Manicassamy, S., Sadim, M., Ye, R. D., and Sun, Z. (2006b). Differential roles of PKC-theta in the regulation of intracellular calcium concentra-tion in primary T cells. J. Mol. Biol. 355, 347-359.
124. Marie, J. C., Letterio, J. J., Gavin, M., and Rudensky, A. Y. (2005). TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061-1067.
125. Marie, J. C., Liggitt, D., and Ruden-sky, A. Y. (2006). Cellular mecha-nisms of fatal early-onset autoim-munity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immu-nity 25, 441-454.
126. Mauri, C., and Ehrenstein, M. R. (2008). The "short" history of reg-ulatory B cells. Trends Immunol. 29, 34-40.
127. McGeachy, M. J., and Anderton, S. M. (2005). Cytokines in the induc-tion and resolution of experimen-tal autoimmune encephalomyelitis. Cytokine 32, 81-84.
128. Mempel, T. R., Pittet, M. J., Khazaie, K., Weninger, W., Weissleder, R., von Boehmer,H.,and vonAndrian,U. H. (2006). Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentia-tion. Immunity 25, 129-141.
129. Mittelstadt, P. R., Yamaguchi, H., Appella, E., and Ashwell, J. D. (2009). T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity. J. Biol. Chem. 284, 15469-15474.
130. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Pari-zot, C., Taflin, C., Heike, T., Valeyre, D., Mathian, A., Nakahata, T., Yam-aguchi, T., Nomura, T., Ono, M., Amoura, Z., Gorochov, G., and Sak-aguchi, S. (2009). Functional delin-eation and differentiation dynamics of human CD4+ T cells express-ing the FoxP3 transcription factor. Immunity 30, 899-911.
131. Moore, K. W., de Waal, M. R., Coff-man, R. L., and 'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
132. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., and Kronenberg, M. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and sup-pressive function in mice with coli-tis. Nat. Immunol. 10, 1178-1184.
133. Nagaleekar, V. K., Diehl, S. A., Jun-cadella,I.,Charland,C.,Muthusamy, N., Eaton, S., Haynes, L., Garrett-Sinha, L. A., Anguita, J., and Rincon, M. (2008). IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program. J. Immunol. 181, 8315-8322.
134. Nakamura, K., Kitani,A., Fuss, I., Peder-sen, A., Harada, N., Nawata, H., and Strober, W. (2004). TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172, 834-842.
135. Nakamura, K., Kitani, A., and Strober, W. (2001). Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629-644.
136. Oberle, N., Eberhardt, N., Falk, C. S., Krammer, P. H., and Suri-Payer, E. (2007). Rapid suppres-sion of cytokine transcription in human CD4+CD25 T Cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol. 179, 3578-3587.
137. Oderup, C., Cederbom, L., Makowska, A., Cilio, C. M., and Ivars, F. (2006). Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on den-dritic cells in CD4+ CD25+ regu-latory T-cell-mediated suppression. Immunology 118, 240-249.
138. Ohashi, P. S., and Yeh, W. C. (2006). Supressing the supressors. Nat. Med. 12, 1000-1002.
139. Oh-Hora, M., and Rao, A. (2008). Cal-cium signaling in lymphocytes. Curr. Opin. Immunol. 20, 250-258.
140. Oh-Hora, M., Yamashita, M., Hogan, P. G., Sharma, S., Lamperti, E., Chung, W., Prakriya, M., Feske, S., and Rao, A. (2008). Dual functions for the endoplasmic reticulum calcium sen-sors STIM1 and STIM2 in T cell acti-vation and tolerance. Nat. Immunol. 9, 432-443.
141. Omilusik, K., Priatel, J. J., Chen, X., Wang, Y. T., Xu, H., Choi, K. B., Gopaul, R., McIntyre-Smith,A., Teh, H. S., Tan, R., Bech-Hansen, N. T., Waterfield, D., Fedida, D., Hunt, S. V., and Jefferies, W. A. (2011). The Ca(v)1.4 calcium channel is a criti-cal regulator of T cell receptor sig-naling and naive T cell homeostasis. Immunity 35, 349-360.
142. Onishi, Y., Fehervari, Z., Yamaguchi, T., and Sakaguchi, S. (2008). Foxp3+ natural regulatory T cells preferen-tially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105, 10113-10118.
143. Oruganti, S. R., Edin, S., Grund-strom, C., and Grundstrom, T. (2011). CaMKII targets Bcl10 in T-cell receptor induced activation of NF-kappaB. Mol. Immunol. 48, 1448-1460.
144. Osorio, F., LeibundGut-Landmann, S., Lochner, M., Lahl, K., Sparwasser, T., Eberl,G.,and Reis e Sousa,C. (2008). DC activated via dectin-1 convert Treg into IL-17 producers. Eur. J. Immunol. 38, 3274-3281.
145. Palkowitsch, L., Marienfeld, U., Brun-ner, C., Eitelhuber, A., Krappmann, D., and Marienfeld, R. B. (2011). The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1/Bcl10/Malt1 complex during T cell receptor induced NF-{kappa}B activation. J. Biol. Chem. 286, 7522-7534.
146. Pandiyan, P., Conti, H. R., Zheng, L., Peterson, A. C., Mathern, D. R., Hernandez-Santos, N., Edgerton, M., Gaffen, S. L., and Lenardo, M. J. (2011). CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34, 422-434.
147. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M. J. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353-1362.
148. Park, C. Y., Shcheglovitov, A., and Dolmetsch, R. (2010). The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330, 101-105.
149. Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., and Allison, J. P. (2009). Blockade of CTLA-4 on both effector and regulatory T cell com-partments contributes to the anti-tumor activity of anti-CTLA-4 anti-bodies. J. Exp. Med. 206, 1717-1725.
150. Peiser, M., Becht, A., and Wanner, R. (2007). Antibody blocking of MHC II on human activated regulatory T cells abrogates their suppressive potential. Allergy 62, 773-780.
151. Perkins, N. D. (2006). Post-translational modifications regulating the activ-ity and function of the nuclear fac-tor kappa B pathway. Oncogene 25, 6717-6730.
152. Pfeifhofer, C., Kofler, K., Gruber, T., Tabrizi,N. G.,Lutz,C.,Maly,K.,Leit-ges, M., and Baier, G. (2003). Protein kinase C theta affects Ca2+ mobi-lization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197, 1525-1535.
153. Piccirillo, C. A., Letterio, J. J., Thorn-ton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H., and Shevach, E. M. (2002). CD4(+)CD25(+) regu-latory T cells can mediate suppressor function in the absence of trans-forming growth factor beta1 pro-duction and responsiveness. J. Exp. Med. 196, 237-246.
154. Pierau, M., Engelmann, S., Reinhold, D., Lapp, T., Schraven, B., and Bommhardt, U. H. (2009). Pro-tein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell forma-tion. J. Immunol. 183, 6124-6134.
155. Pillai, V., and Karandikar, N. J. (2008). Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 111, 463-464.
156. Pillai, V., Ortega, S. B., Wang, C. K., and Karandikar, N. J. (2007). Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123, 18-29.
157. Podtschaske, M., Benary, U., Zwinger, S., Hofer, T., Radbruch, A., and Baum-grass, R. (2007). Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression. PLoS ONE 2, e935. doi:10.1371/jour-nal.pone.0000935
158. Qi, Q., and August, A. (2007). Keep-ing the (kinase) party going: SLP-76 and ITK dance to the beat. Sci. STKE 2007, e39.
159. Quintana, A., Griesemer, D., Schwarz, E. C., and Hoth, M. (2005). Calcium-dependent activation of T-lymphocytes. Pflugers Arch. 450, 1-12.
160. Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S., and Sansom, D. M. (2011). Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603.
161. Ranger, A. M., Oukka, M., Ren-garajan, J., and Glimcher, L. H. (1998). Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9, 627-635.
162. Rao, A., Luo, C., and Hogan, P. G. (1997). Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
163. Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Fran-cisco, L., Sharpe, A. H., and Powrie, F. (2006). Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383.
164. Read, S., Malmstrom, V., and Powrie, F. (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302.
165. Ren, X., Ye, F., Jiang, Z., Chu, Y., Xiong, S., and Wang, Y. (2007). Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regu-latory T cells. Cell Death Differ. 14, 2076-2084.
166. Roncador, G., Brown, P. J., Maestre, L., Hue, S., Martinez-Torrecuadrada, J. L., Ling, K. L., Pratap, S., Toms, C., Fox, B. C., Cerundolo, V., Powrie, F., and Banham, A. H. (2005). Analy-sis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35, 1681-1691.
167. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., and Levings, M. K. (2006). Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50.
168. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A. Y. (2010). Sta-bility of the regulatory T cell lineage in vivo. Science 329, 1667-1671.
169. Rubtsov,Y. P.,Rasmussen,J. P.,Chi,E.Y., Fontenot, J., Castelli, L.,Ye, X., Treut-ing, P., Siewe, L., Roers, A., Hender-son,W. R. Jr.,Muller,W.,and Ruden-sky, A. Y. (2008). Regulatory T cell-derived interleukin-10 limits inflam-mation at environmental interfaces. Immunity 28, 546-558.
170. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M., and Wagner, E. F. (2001). c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 193, 317-328.
171. Sakaguchi, S. (2004). Naturally aris-ing CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
172. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance main-tained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mecha-nism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
173. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W. (1999). IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356.
174. Sarris, M., Andersen, K. G., Randow, F., Mayr, L., and Betz, A. G. (2008). Neuropilin-1 expression on regula-tory T cells enhances their inter-actions with dendritic cells during antigen recognition. Immunity 28, 402-413.
175. Schmidt, A., Oberle, N., Weiß, E.-M., Vobis, D., Frischbutter, S., Baum-grass, R., Falk, C. S., Haag, M., Brügger, B., Lin, H., Mayr, G. W., Reichardt, P., Gunzer, M., Suri-Payer, E., and Krammer, P. H. (2011). Human regulatory T cells rapidly suppress T cell receptor-induced Ca2+, NF-kB, and NFAT signaling in conventional T cells. Sci. Signal. 4, ra90.
176. Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B., Hogg, N., Garside, P., and Rudd, C. E. (2006). Reversal of the TCR stop signal by CTLA-4. Science 313, 1972-1975.
177. Schwarzmann, N., Kunerth, S., Weber, K., Mayr, G. W., and Guse, A. H. (2002). Knock-down of the type 3 ryanodine receptor impairs sus-tained Ca2+ signaling via the T cell receptor/CD3 complex. J. Biol. Chem. 277, 50636-50642.
178. Serfling, E., Chuvpilo, S., Liu, J., Hofer, T., and Palmetshofer, A. (2006). NFATc1 autoregulation: a crucial step for cell-fate determination. Trends Immunol. 27, 461-469.
179. Sica, A., Dorman, L., Viggiano, V., Cip-pitelli, M., Ghosh, P., Rice, N., and Young, H. A. (1997). Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 272, 30412-30420.
180. Smith-Garvin, J. E., Koretzky, G. A., and Jordan, M. S. (2009). T cell activation. Annu. Rev. Immunol. 27, 591-619.
181. Sojka, D. K., and Fowell, D. J. (2011). Regulatory T cells inhibit acute IFN-gamma synthesis without blocking T-helper cell type 1 (Th1) differ-entiation via a compartmentalized requirement for IL-10. Proc. Natl. Acad. Sci. U.S.A. 108, 18336-18341.
182. Sojka, D. K., Hughson, A., Sukien-nicki, T. L., and Fowell, D. J. (2005). Early kinetic window of target T cell susceptibility to CD25+ regula-toryTcellactivity.J. Immunol. 175, 7274-7280.
183. Song, X. T., Evel-Kabler, K., Shen, L., Rollins, L., Huang, X. F., and Chen, S. Y. (2008). A20 is an antigen pre-sentation attenuator, and its inhi-bition overcomes regulatory T cell-mediated suppression. Nat. Med. 14, 258-265.
184. Soto-Nieves, N., Puga, I., Abe, B. T., Bandyopadhyay, S., Baine, I., Rao, A., and Macian, F. (2009). Transcrip-tional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J. Exp. Med. 206, 867-876.
185. Spencer, S. D., Di Marco, F., Hooley, J., Pitts-Meek, S., Bauer, M., Ryan, A. M., Sordat, B., Gibbs, V. C., and Aguet, M. (1998). The orphan recep-tor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187, 571-578.
186. Stephens, L. A., Mottet, C., Mason, D., and Powrie, F. (2001). Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune sup-pressive activity in vitro. Eur. J. Immunol. 31, 1247-1254.
187. Stummvoll, G. H., DiPaolo, R. J., Huter, E. N., Davidson, T. S., Glass, D., Ward, J. M., and Shevach, E. M. (2008). Th1, Th2, and Th17 effector T cell-induced autoimmune gastri-tis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 181, 1908-1916.
188. Sukiennicki, T. L., and Fowell, D. J. (2006). Distinct molecular program imposed on CD4+ T cell targets by CD4+CD25+ regulatory T cells. J. Immunol. 177, 6952-6961.
189. Sumoza-Toledo, A., Eaton, A. D., and Sarukhan, A. (2006). Regulatory T cells inhibit protein kinase C theta recruitment to the immune synapse of naive T cells with the same antigen specificity. J. Immunol. 176, 5779-5787.
190. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., and Littman, D. R. (2000). PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404, 402-407.
191. Suri-Payer, E., and Fritzsching, B. (2006). Regulatory T cells in experimental autoimmune disease. Springer Semin. Immunopathol. 28, 3-16.
192. Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S., and Rouse, B. T. (2003). CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198, 889-901.
193. Szymczak-Workman, A. L., Delgoffe, G. M., Green, D. R., and Vignali, D. A. (2011). Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. J. Immunol. 187, 4416-4420.
194. Szymczak-Workman, A. L., Workman, C. J., and Vignali, D. A. (2009). Cut-ting edge: regulatory T cells do not require stimulation through their TCR to suppress. J. Immunol. 182, 5188-5192.
195. Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W., and Akbar, A. N. (2001). Human aner-gic/suppressive CD4(+)CD25(+)T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31, 1122-1131.
196. Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Mar-aver, A., Lafaille, J. J., and Dustin, M. L. (2006). Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cellsinvivo.J. Exp. Med. 203, 505-511.
197. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu,J.,and Sakaguchi,S. (1998). Immunologic self-tolerance main-tained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980.
198. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak,T. W.,and Sakaguchi,S. (2000). Immunologic self-tolerance main-tained by CD25(+)CD4(+) regula-tory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
199. Tanchot, C., Vasseur, F., Pontoux, C., Garcia, C., and Sarukhan, A. (2004). Immune regulation by self-reactive T cells is antigen specific. J. Immunol. 172, 4285-4291.
200. Tang, Q., and Bluestone, J. A. (2008). The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244.
201. Tang, Q., Boden, E. K., Henriksen, K. J., Bour-Jordan, H., Bi, M., and Bluestone, J. A. (2004). Dis-tinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996-3005.
202. Tang, Q., and Krummel, M. F. (2006). Imaging the function of regulatory T cells in vivo. Curr. Opin. Immunol. 18, 496-502.
203. Thornton, A. M., Donovan, E. E., Pic-cirillo, C. A., and Shevach, E. M. (2004a). Cutting edge: IL-2 is criti-cally required for the in vitro acti-vation of CD4+CD25+ T cell sup-pressor function. J. Immunol. 172, 6519-6523.
204. Thornton, A. M., Piccirillo, C. A., and Shevach, E. M. (2004b). Activa-tion requirements for the induction of CD4+CD25+ T cell suppres-sor function. Eur. J. Immunol. 34, 366-376.
205. Thornton, A. M., and Shevach, E. M. (1998). CD4+CD25+ immunoreg-ulatory T cells suppress polyclonal T cell activation in vitro by inhibit-ing interleukin 2 production. J. Exp. Med. 188, 287-296.
206. Thornton, A. M., and Shevach, E. M. (2000). Suppressor effector func-tion of CD4+CD25+ immunoregu-latory T cells is antigen nonspecific. J. Immunol. 164, 183-190.
207. Tran, D. Q., Glass, D. D., Uzel, G., Darnell, D. A., Spalding, C., Hol-land, S. M., and Shevach, E. M. (2009). Analysis of adhesion mol-ecules, target cells, and role of IL-2 in human FOXP3+ regulatory Tcell suppressor function. J. Immunol. 182, 2929-2938.
208. Tran, D. Q., Ramsey, H., and She-vach, E. M. (2007). Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transform-ing growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990.
209. Travis, M. A., Reizis, B., Melton, A. C., Masteller, E., Tang, Q., Proctor, J. M., Wang, Y., Bernstein, X., Huang, X., Reichardt, L. F., Bluestone, J. A., and Sheppard, D. (2007). Loss of inte-grin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365.
210. Trushin, S. A., Pennington, K. N., Algeciras-Schimnich, A., and Paya, C. V. (1999). Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytes. J. Biol. Chem. 274, 22923-22931.
211. Uhlig, H. H., Coombes, J., Mot-tet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., and Powrie, F. (2006). Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ Tcells during cure of colitis. J. Immunol. 177, 5852-5860.
212. Vaeth, M., Gogishvili, T., Bopp, T., Klein, M., Berberich-Siebelt, F., Gatten-loehner, S., Avots, A., Sparwasser, T., Grebe,N.,Schmitt,E.,Hunig,T.,Ser-fling, E., and Bodor, J. (2011). Reg-ulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl. Acad. Sci. U.S.A. 108, 2480-2485.
213. Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
214. van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., and Davis, S. J. (1997). CD80 (B7-1) binds both CD28 and CTLA-4 with a low affin-ity and very fast kinetics. J. Exp. Med. 185, 393-403.
215. Veldhoen, M., Moncrieffe, H., Hocking, R. J., Atkins, C. J., and Stockinger, B. (2006). Modulation of dendritic cell function by naive and regula-tory CD4+ T cells. J. Immunol. 176, 6202-6210.
216. Vercoulen, Y., Wehrens, E. J., van Tei-jlingen, N. H., de Jager, W., Beek-man, J. M., and Prakken, B. J. (2009). Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells. PLoS ONE 4, e7183. doi:10.1371/journal.pone.0007183
217. Villarino,A.V.,Tato,C. M.,Stumhofer,J. S., Yao, Z., Cui, Y. K., Hennighausen, L., 'Shea, J. J., and Hunter, C. A. (2007). Helper T cell IL-2 produc-tion is limited by negative feed-back and STAT-dependent cytokine signals. J. Exp. Med. 204, 65-71.
218. Voo, K. S., Wang, Y. H., Santori, F. R., Boggiano, C., Wang, Y. H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., Zheng, B., Littman, D. R., and Liu, Y. J. (2009). Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U.S.A. 106, 4793-4798.
219. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., Van, L. M., Buck-ner, J. H., and Ziegler, S. F. (2003). Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin. Invest. 112, 1437-1443.
220. Walunas, T. L., Bakker, C. Y., and Blue-stone, J. A. (1996). CTLA-4 ligation blocks CD28-dependent T cell acti-vation. J. Exp. Med. 183, 2541-2550.
221. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., and Bluestone, J. A. (1994). CTLA-4 can function as a negative regula-tor of T cell activation. Immunity 1, 405-413.
222. Wang, J., Ioan-Facsinay, A., van, D. V., Huizinga, T. W., and Toes, R. E. (2007). Transient expression of FOXP3 in human activated non-regulatory CD4+ T cells. Eur. J. Immunol. 37, 129-138.
223. Wang, Y., Deng, X., Mancarella, S., Hendron, E., Eguchi, S., Soboloff, J., Tang, X. D., and Gill, D. L. (2010). The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 330, 105-109.
224. Wang, Y., Su, M. A., and Wan, Y. Y. (2011). An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immu-nity 35, 337-348.
225. Wehrens, E. J., Mijnheer, G., Duurland, C. L., Klein, M., Meerding, J., van Loosdregt, J., de Jager, W., Sawitzki, B., Coffer, P. J., Vastert, B., Prakken, B. J., and van Wijk, F. (2011). Func-tional human regulatory T cells fail to control autoimmune inflamma-tion due to PKB/c-akt hyperacti-vation in effector cells. Blood 118, 3538-3548.
226. Werlen, G., Jacinto, E., Xia, Y., and Karin, M. (1998). Calcineurin pref-erentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17, 3101-3111.
227. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sak-aguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell func-tion. Science 322, 271-275.
228. Wohlfert, E. A., Callahan, M. K., and Clark, R. B. (2004). Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/-mice. J. Immunol. 173, 1059-1065.
229. Wohlfert, E. A., and Clark, R. B. (2007). "Vive la Resistance!" -the PI3K-Akt pathway can determine tar-get sensitivity to regulatory T cell suppression. Trends Immunol. 28, 154-160.
230. Wohlfert, E. A., Grainger, J. R., Bouladoux, N., Konkel, J. E., Old-enhove, G., Ribeiro, C. H., Hall, J. A., Yagi, R., Naik, S., Bhairavabhotla, R., Paul, W. E., Bosselut, R., Wei, G., Zhao, K., Oukka, M., Zhu, J., and Belkaid, Y. (2011). GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503-4515.
231. Workman, C. J., and Vignali, D. A. (2005). Negative regulation of T cell homeostasis by lymphocyte activa-tion gene-3 (CD223). J. Immunol. 174, 688-695.
232. Xu, L., Kitani, A., Fuss, I., and Strober, W. (2007). Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exoge-nous TGF-beta. J. Immunol. 178, 6725-6729.
233. Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., and Sakaguchi, S. (2004). Crucial role of FOXP3 in the devel-opment and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643-1656.
234. Yan, Z., Garg, S. K., and Banerjee, R. (2010). Regulatory T cells interfere with glutathione metabolism in den-dritic cells and T cells. J. Biol. Chem. 285, 41525-41532.
235. Yan,Z.,Garg,S. K.,Kipnis,J.,and Baner-jee, R. (2009). Extracellular redox modulation by regulatory T cells. Nat. Chem. Biol. 5, 721-723.
236. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., Feng, X. H., Jetten, A. M., and Dong, C. (2008). Mol-ecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56.
237. Yang, X. O., Panopoulos, A. D., Nurieva, R., Chang, S. H., Wang, D., Watowich, S. S., and Dong, C. (2007). STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358-9363.
238. Yao,Z.,Kanno,Y.,Kerenyi,M.,Stephens, G., Durant, L., Watford, W. T., Lau-rence, A., Robinson, G. W., Shevach, E. M., Moriggl, R., Hennighausen, L., Wu, C., and 'Shea, J. J. (2007). Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375.
239. Young, H. A. (1996). Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 16, 563-568.
240. Zarek, P. E., Huang, C. T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., and Powell, J. D. (2008). A2A receptor signaling pro-motes peripheral tolerance by induc-ing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251-259.
241. Zheng, Y., Chaudhry, A., Kas, A., DeRoos, P., Kim, J. M., Chu, T. T., Corcoran, L., Treuting, P., Klein, U., and Rudensky, A. Y. (2009). Reg-ulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356.
242. Zheng, Y., Manzotti, C. N., Burke, F., Dussably, L., Qureshi, O., Walker, L. S., and Sansom, D. M. (2008). Acquisition of suppressive function by activated human CD4+CD25-T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 181, 1683-1691.
243. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Vic-tora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., Ziegler, S. F., and Littman, D. R. (2008). TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat func-tion. Nature 453, 236-240.
244. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., and Bluestone, J. A. (2009). Instability of the tran-scription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
245. Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307.